About the Company
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd., originally known as Heze Ruiying Pharmaceutical Group Co., Ltd., is a large medicine manufacturer integrating scientific research, pilot plant test, manufacturing and sales, covering biological fermentation, chemical synthesis, aseptic pharmacy, etc. and forming complete industrial chain. The company now has 1,500 employees, above 40% of which are various professional technici...
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd., originally known as Heze Ruiying Pharmaceutical Group Co., Ltd., is a large medicine manufacturer integrating scientific research, pilot plant test, manufacturing and sales, covering biological fermentation, chemical synthesis, aseptic pharmacy, etc. and forming complete industrial chain. The company now has 1,500 employees, above 40% of which are various professional technicians. With global advanced technical level, it has 95% products developed independently, partially filling in the domestic blanks. It has passed the certifications of Quality Management System, Goods Manufacturing Practice (GMP) of State Food and Drug Administration, EHS and South Korea KFDA and possessed proprietary import and export rights. Besides domestic market, it has tapped the markets of dozens of countries in Europe and America.
Powerful in scientific research strength, it has a high-level R&D team cored with doctors, masters and part foreign experts. A large amount of first-class high-tech products have been researched and developed, including 30 scientific research achievements with provincial appraisal and many rewards and 8 domestically unique projects with international advanced level.
Its production system has formed the complete product chain from upper-stream products, middle-stream products and lower-stream products. The products are divided into five product platforms, eight series and more than 100 varieties: pharmaceutical Intermediates, aseptic raw drugs, biological pharmacy, anti-neoplastic drugs and pharmaceutical preparations. ① The pharmaceutical Intermediates mainly include more than 40 varieties, such as GCLE, HO-EPCP, EPCP, TAEM, formyl chloride, etc. ② The pharmaceutical raw material platform includes raw material coarse powder and aseptic raw drugs, mainly producing cephems and penicillin raw drugs. The cephems mainly have cefoperazone, ceftriaxone, ceftazidime, cefuroxime, cefpiramide, cefotiam, cefixime, etc. The penicillin mainly includes piperacillin, mezlocilline, azlocillin, flucloxacillin, sulbactam, etc. ③ The biotechnology platforms are mainly applied for biological pharmacy and biological fermentation, including 7-ACA, clavulanic acid, erythromycin, epothilones, etc. ④ The main anti-neoplastic drugs include nimustine, fotemustine, ifosfamide, dicarbazine, natarii norcantharidatis, etc. ⑤ The pharmaceutical preparations are mainly anti-neoplastic drugs.
The company has sound quality guarantee system, environmental protection system, supply and sales systems and management system.
In recent years, it has strengthened foreign cooperation. Now, it has established excellent cooperative relationships with some large companies abroad for mutual benefits and common development.
The company has strengthened energy saving and emission reduction as well as environmental protection treatment, implemented circular economy, resource comprehensive utilization and sewage zero drainage engineering.
It will constantly strengthen technological innovation and market development by virtue of its own advantages, thus speeding up its development and developing itself into the most professional antibiotic pharmacy company in shortest time.
Related Companies
Market Place
